Product Pathways
BCP0001 GDC-0941
GDC-0941 is a potent inhibitor of PI3Kα, PI3Kβ, PI3Kδ and PI3Kγ ;10G in stock
BCP0008 GSK690693
aminofurazan-derived inhibitor of Akt kinases with potential antine
BCP0014 ADL5859
ADL-5859 is an agonist agents that selectively stimulate the δ-opioid receptor with potential application in a wide range of inflammatory, neuropathic and acute pain conditions.
BCP0026 Belinostat
Belinostat (PXD101) is a novel hydroxamate-type inhibitor of histone deacetylase (HDAC) activity.
BCP0027 BEZ235
Orally active PI3K tyrosine kinase inhibitor
BCP0293 Naratriptan(Amerge)
Naratriptan (Amerge) is a triptan agent that is used for the treatment of migraine headaches.
BCP0102 PL-100
PL-100 is a novel HIV-1 protease inhibitor (PI) with a favorable cross-resistance profile and high genetic barrier.
BCP0107 Rapamycin
Rapamycin (Sirolimus, AY-22989, WY-090217) is a specific mTOR inhibitor.
BCP0113 SB216763
SB216763 is a potent and selective GSK-3α inhibitor.
BCP0125 Temsirolimus
Temsirolimus (also known as CCI-779) is a recently developed mTOR inhibitor.
第一页 1 2 3 4 5 6 7 8 9 10 下10页 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.